• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sage Therapeutics Inc

+ Add to Watchlist

SAGE:US

40.1900 USD 0.1300 0.32%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Sage Therapeutics Inc (SAGE)

Open: 40.4000 Day's Range: 39.1500 - 41.8351 Volume: 880,043
Previous Close: 40.3200 52wk Range: 24.2500 - 44.9800 1-Yr Rtn: -

Stock Chart for SAGE

No chart data available.
  • SAGE:US 40.1900
  • 1D
  • 1M
  • 1Y
40.3200
Interactive SAGE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SAGE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.5650
Est. PEG Ratio -
Market Cap (M USD) 1,036.61
Shares Outstanding (M) 25.79
30 Day Average Volume 117,672
Price/Book (mrq) 7.7364
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SAGE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SAGE

Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the United States.

Jeffrey M Jonas "Jeff"President/CEOKimi IguchiChief Financial Officer
Stephen J KanesChief Medical OfficerAlbert J RobichaudChief Scientific Officer
More Company Profile & Key Executives for SAGE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil